Geneva-based medtech company Spineart has secured a CHF 25M capital increase, backed by long-term investors Gimv and EGS Beteiligungen (EGSB).
The funding will drive Spineart’s next phase of profitable expansion, strengthening its global presence and advancing its innovation pipeline in spine surgery solutions.
Scaling surgical innovation worldwide
The startup develops cutting-edge technologies that make spine surgery safer, more efficient, and more effective. With a strong focus on clinical outcomes, the company is scaling across Europe and the U.S., where it has ongoing FDA submissions for its BAGUERA® C cervical disc.
The firm is also investing in digital navigation and robotics, signaling its ambition to integrate transformative technologies into spine surgery.
Advertisement
Strong momentum and growth outlook
Spineart employs over 360 professionals worldwide and is on track to reach €140M in revenue in 2025, marking five consecutive years of double-digit growth at an average +16% CAGR.
A newly opened production facility in Reignier, France, gives the company additional manufacturing capacity to meet growing demand globally.
Investor confidence in long-term vision
“This investment represents a major milestone in Spineart’s profitable growth journey,” said Jerome Trividic, CEO of Spineart. “With the continued support of Gimv and EGSB, we are well-positioned to scale globally, deliver innovative technologies, and reinforce our commitment to surgical excellence and better patient outcomes.”
Gimv, one of Spineart’s lead backers, emphasized the company’s international growth potential. “Our sustained commitment to Spineart reflects our strong belief in its innovation capabilities in spine surgery,” said Bart Diels and Gautier Lefebvre of Gimv. “This investment fits perfectly with our ambition to support pioneering healthcare companies shaping the future of patient care.”
EGSB echoed this confidence: “Our additional investment underscores our dedication to fostering entrepreneurship and helping innovative businesses scale internationally,” said Dominik Sauter and Christian Pfab.
The bigger picture
The company is positioning itself as a global leader in advanced spine surgery solutions, combining product innovation, robotics, and regulatory expansion to build on its profitable growth trajectory. With backing from committed investors, the company is set to accelerate its international footprint and lead the next wave of surgical innovation.
